Cara Therapeutics
CARA
#10496
Rank
A$11.32 M
Marketcap
A$7.43
Share price
-2.56%
Change (1 day)
5.99%
Change (1 year)

Earnings for Cara Therapeutics (CARA)

Earnings in 2024 (TTM): -A$95.06 Million

According to Cara Therapeutics 's latest financial reports the company's current earnings are A$7.13 Million. , an increase over its 2023 earnings that were of -A$0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cara Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 -A$87.67 Million-45.49%
2023 -A$0.17 Billion31.6%
2022 -A$0.13 Billion-1.74%
2021 -A$0.13 Billion-1754.28%
2020 A$7.51 M-104.82%
2019 -A$0.16 Billion44.32%
2018 -A$0.11 Billion30.09%
2017 -A$83.05 Million1.86%
2016 -A$81.53 Million131.86%
2015 -A$35.17 Million39.38%
2014 -A$25.23 Million9120.41%
2013 -A$0.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$46.84 B-53,533.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.22 B-16,331.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
-A$43.36 Million-50.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
A$5.25 M-105.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
-A$0.12 Billion 26.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.38 Billion 332.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
-A$14.37 Million-83.62%๐Ÿ‡บ๐Ÿ‡ธ USA